... 近20年来ALL治疗已取得了显著进步，联合化疗、支持治疗和庇护所预防性治疗使ALL患儿 的5年无事件生存率（event free survival，EFS）接近80％n】。
基于22个网页-相关网页
event-free survival 无事件生存率 ; 无事件生存期
Event Free Survival EFS 无事件生存
5 year event-free survival 年无事件生存率
First results from a French study comparing single versus double autologous transplantation have shown a benefit in terms of event-free survival for the sequential approach.
最先的一项来自法国的研究结果表明，比较单自体移植对双自体移植，对在后继的无病生存方面的研究有帮助。
Objective To investigate the relationship between immunophenotype and event-free survival (EFS) in children with acute lymphoblastic leukemia (ALL).
目的探讨儿童急性淋巴细胞白血病(all)免疫表型与无病生存期(EFS)的关系。
In the group with unfavorable features, 5-year event-free survival and estimates of 10-year overall survival were similar in all treatment groups and for each time period, ranging from 84% to 88%.
在情况较差的病人组中，所有组的五年无病生存率以及估测十年总生存率在每个时间段内均相差不多，在84%到88%之间。
应用推荐